amitriptyline has been researched along with Atrioventricular Conduction Block in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Excerpt | Relevance | Reference |
---|---|---|
"The nortriptyline concentration was significantly associated with the QRS interval (pā=ā0." | 1.56 | Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients. ( Deckert, J; Hommers, L; Menke, A; Scherf-Clavel, M; Unterecker, S; Zebner, J, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Scherf-Clavel, M | 1 |
Zebner, J | 1 |
Hommers, L | 1 |
Deckert, J | 1 |
Menke, A | 1 |
Unterecker, S | 1 |
1 other study available for amitriptyline and Atrioventricular Conduction Block
Article | Year |
---|---|
Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients.
Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Tricyclic; Atrioventricular Bl | 2020 |